Bajaj Finserv LtdQ1 FY27
Bajaj Finserv Ltd Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,993P/E: 31.7Market Cap: ₹3.3L CrSector: Finance
Management growth scorecard
Revenue
N/A
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 3 growth signals are positive.
Full analysisRevenue guidance
- →Bajaj Life expects continued growth in retail protection, though at a moderated pace due to a rising base, with risk products like term plans gaining traction (34% of new customers onboarded with term plans last quarter).
- →Group protection business showed significant revival driven by growth in MFI partnerships and new relationships; broad sector diversification ongoing.
- →Bajaj Asset Management aims to grow AUM from INR 31,444 crore to INR 1 lakh crore within 3 years, supporting a path to profitability.
- →Bajaj Markets (digital lending platform) sees growth resuming post enhancements, with unique partner count increasing to 103 and operating revenues growing 32% QoQ.
- →Bajaj General Insurance will tactically manage growth in motor own damage segment, currently slowed due to elevated loss ratios and pricing cycles.
- →Crop and government health insurance businesses expected to grow with contract renewals, supporting steady revenues.
- →Overall, growth will be balanced with margin and risk management, with tactical shifts depending on market cycles.
Margin guidance
Category 3- →Bajaj Life expects continued growth with retail weighted received premium growing at 17.5% and group protection business growing 95% year-on-year, indicating strong future earnings potential.
- →New Business Margin expanded to 15.9%, improving profitability.
- →Bajaj Finserv Direct aims to break even by Q3 or Q4 FY2027 on a quarterly basis and full-year profitability in FY2028.
- →Bajaj Finserv Health targets break-even by Q3 or Q4 FY2028, with full-year profitability the year after.
- →Bajaj Asset Management Company aims to grow AUM from INR 30,000 crore to INR 1 lakh crore in 3 years, driving earnings improvement.
- →Operating efficiencies through AI and enhanced business models signal margin improvements, with expected opex to NTI ratio improvement by 25-40 bps this year.
- →Bajaj General maintains healthy ROE (17.3%) and expects best-in-industry combined ratio despite market challenges, supporting stable profit growth.
- →Overall, steady earnings growth and margin expansion are anticipated across subsidiaries toward FY2028.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →Bajaj Finserv is currently in the process of planning capital requirements for its reinsurance business, which is expected to need some capital infusion in the future, though exact numbers are yet to be finalized.
- →For international expansion (Phase 2 of reinsurance), a larger chunk of capital will be required, but exact figures are not yet quantified.
- →Bajaj Health company may require capital infusion for the next 6 quarters, estimated at INR 200-300 crore.
- →Bajaj Asset Management Company may need a minor capital infusion going forward.
- →Larger capital requirements are expected for the Alternate Investment business (ALTs).
- →No specific current fundraising through debt or equity has been announced at this time.
- →The company has reduced capital recently via buyback and dividends, impacting ROE positively going forward.
Order book
The provided transcript does not explicitly mention details about the current or expected order book or pending orders for Bajaj Finserv Limited. The discussion primarily focuses on insurance segments, product mixes, market conditions, profitability paths, and operational performance across various subsidiaries.
Therefore:
- No specific information on current or expected order book or pending orders is disclosed.
- The call highlights focus areas such as insurance claims, pricing cycles, product mix, digital lending trends, and capital requirements.
- Emphasis on profitability timelines and strategic expansions like setting up reinsurance and alternate investment businesses is noted, but order book details are not provided.
Capex plans
Yes- →Bajaj Finserv plans capital infusion in its Health company for the next 6 quarters, estimated at INR 200-300 crore.
- →Asset Management Company may require some additional capital, though less than prior infusions.
- →A larger capital requirement is anticipated for the Alternate Investments (ALTs) business, their newest segment.
- →The company is planning to set up a reinsurance company, which will require capital over a multi-year timeframe.
- →Capital allocation plan includes a phased approach: initial focus on domestic operations with minimal capital, followed by international expansion over a 3-year period requiring a larger capital chunk.
- →No exact quantification of capital needs for reinsurance yet; still in planning stages.
How does Bajaj Finserv Ltd rank vs peers in Finance?
Pro feature1Bajaj Finserv Ltd
Mar 3
See full Finance sector rankings
How does Bajaj Finserv Ltd rank in Finance?
Compare Bajaj Finserv Ltd against every Finance company (Q1 FY27) on revenue, margins and earnings-call signals.